BHR PHARMACEUTICALS LIMITED

Active Nuneaton

Manufacture of basic pharmaceutical products

18 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
B

BHR PHARMACEUTICALS LIMITED

Manufacture of basic pharmaceutical products

Founded 17 Jan 1990 Active Nuneaton, United Kingdom 18 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 23 Sept 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 17 Jun 2025 Next due 1 Jul 2026 1 month remaining
Net assets £-150K £41K 2024 year on year
Total assets £1M £253K 2024 year on year
Total Liabilities £1M £293K 2024 year on year
Charges 6
6 satisfied

Contact & Details

Contact

Registered Address

1 Kingfisher Court Hemdale Business Park Nuneaton Warwickshire CV11 6GY United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BHR PHARMACEUTICALS LIMITED (02460338), an active life sciences and medical technology company based in Nuneaton, United Kingdom. Incorporated 17 Jan 1990. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£408.95k

Decreased by £332.85k (-45%)

Net Assets

-£149.56k

Increased by £40.66k (+21%)

Total Liabilities

£1.48M

Decreased by £293.31k (-17%)

Turnover

N/A

Employees

18

Decreased by 1 (-5%)

Debt Ratio

111%

Decreased by 1 (-1%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (3)

Biosynex S.a
100.0%
38,300
Paresh Kotecha
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Biosynex S.a

France

Active
Notified 19 May 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Rameshkumar Jerambhai Patel

Ceased 19 May 2022

Ceased

Group Structure

Group Structure

BHR PHARMACEUTICALS LIMITED Current Company

Charges

Charges

6 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit 1, Kingfisher Court, Hemdale Business Park, Nuneaton (CV11 6GY) NUNEATON AND BEDWORTH
Leasehold-16 Nov 2023
Unit 1, Kingfisher Court, Hemdale Business Park, Nuneaton (CV11 6GY)
Leasehold
Added 16 Nov 2023
District NUNEATON AND BEDWORTH

Documents

Company Filings

DateCategoryDescriptionDocument
12 Jan 2026OfficersAppointment of Mr Oren Isaac Bitton as director on 15 Dec 2025
12 Jan 2026OfficersTermination of Thomas Lamy as director on 15 Dec 2025
24 Oct 2025OfficersTermination of Rameshkumar Jerambhai Patel as director on 9 Mar 2025
23 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
17 Jun 2025Confirmation StatementConfirmation statement made on 17 Jun 2025 with updates
12 Jan 2026 Officers

Appointment of Mr Oren Isaac Bitton as director on 15 Dec 2025

12 Jan 2026 Officers

Termination of Thomas Lamy as director on 15 Dec 2025

24 Oct 2025 Officers

Termination of Rameshkumar Jerambhai Patel as director on 9 Mar 2025

23 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

17 Jun 2025 Confirmation Statement

Confirmation statement made on 17 Jun 2025 with updates

Recent Activity

Latest Activity

Appointment of Mr Oren Isaac Bitton as director on 15 Dec 2025

4 months ago on 12 Jan 2026

Termination of Thomas Lamy as director on 15 Dec 2025

4 months ago on 12 Jan 2026

Termination of Rameshkumar Jerambhai Patel as director on 9 Mar 2025

7 months ago on 24 Oct 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 23 Sept 2025

Confirmation statement made on 17 Jun 2025 with updates

11 months ago on 17 Jun 2025